Melanie Ott, MD, PhD
Program Director, Principal Investigator, co-Director Research Focus 3
Melanie Ott, MD, PhD
Program Director, Principal Investigator, co-Director Research Focus 3
Dr. Melanie Ott trained with tumor virologist and Nobel laureate Harald zur Hausen in Heidelberg/Germany and has focused much of her work on the role of reversible protein acetylation in HIV transcription and identifying molecular mechanisms controlling viral latency. She is the recipient of NIH MERIT and DP1 Avantgarde Awards, a member of the Association of American Physicians and a fellow of the American Academy of Microbiology.